IHM
ABBV icon

Iguana Healthcare Management’s AbbVie ABBV Stock Holding History

Iguana Healthcare Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$3.1M – 80
2016
Q2 		$3.1M Buy
+50,000
New +$3.05M 1.26% 28
2015
Q4 		– Sell
-60,000
Closed -$3.26M – 65
2015
Q3 		$3.26M Buy
+60,000
New +$3.91M 1.28% 25

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Iguana Healthcare Management's ABBV Position: Q1 2018 in Review

Iguana Healthcare Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 50,000 shares — an estimated $4.84M sold.

Iguana Healthcare Management first reported a position in ABBV in Q2 2014 and held it in 7 quarters. The position peaked at $7.22M in Q3 2014. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • Iguana Healthcare Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 AbbVie shares in Q1 2018, an estimated $4.84M.
  • Iguana Healthcare Management first reported a position in AbbVie in Q2 2014 and held it in 7 quarters.
  • Iguana Healthcare Management's AbbVie position peaked at $7.22M in Q3 2014.
  • 2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.